Bibliographys
- CRANSWICK N, COGHLAN D: Paracetamol efficacy and safety in children: the first 40 years. Am.j Ther. (2000) 7:135–141.
- JORDAN KM, ARDEN NK, DOHERTY M et al: EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis. Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann. Rheum. D AK (2003) 62:1145–1155.
- AMERICAN GERIATRICS SOCIETY PANEL ON PERSISTENT PAIN IN OLDER PERSONS: The management of persistent pain in older persons. J. Am. Geriatr. Soc. (2002) 50:S205–S224.
- RAHME E, PETTITT D, LELORIERJ: Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal anti-inflammatory drugs in an elderly population. Arthritis Rheum. (2002) 46:3046–3054.
- •A study assessing the determinants of paracetamol prescription in clinical practice.
- LANZA FL, CODISPOTI JR, NELSON EB: An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen. Am.' Gastroenterol (1998) 93:1051–1054.
- IVEY KJ: Gastrointestinal effects of antipyretic analgesics. Am. Med. (1983) 75(Suppl. 5A):53–64.
- HOLVOET J, TERRIERE L, VAN HEE W, VERBIST L, FIERENS E, HAUTEKEETE ML: Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study. Gut (1991) 32:730–734.
- CARVAJAL A, PRIETO JR, ALVAREZ REQUEJO A, MARTIN ARIAS LH: Aspirin or acetaminophen? A comparison from data collected by the Spanish Drug Monitoring System. I Clio. Epidemiol (1996) 49:255–261.
- CRYER B, FELDMAN M: Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am. I Med. (1998) 104:413–423.
- GARCIA RODRIGUEZ LA, HERNANDEZ-DIAZ S: Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology (2001) 12:570–576.
- LIPWORTH L, SOREN F, MELLEMKJAER L et al.: A population-based cohort study of mortality among adults prescribed paracetamol in Denmark. J. Clio. Epidemiol. (2003) 56:796–801.
- ••An illustration of confoundingby indication.
- LEWIS SC, LANGMAN MJ, LAPORTE JR, MATTHEWS JN, RAWLINS MD, WIHOLM BE: Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious gastrointestinal bleeding: a meta-analysis based on individual patient data. Br. Cl/n. Pharmacol (2002) 54:320–326.
- ••A clear explanation on how informationabout drug exposure influences the results of case-control studies.
- LANGMAN MJ, WEIL J, WAINWRIGHT P et al.: Risks of bleeding peptic ulcer associated with non-steroidal anti-inflammatory drugs. Lancet (1994) 343:1075–1078.
- LANAS A, SERRANO P, BAJADOR E, FUENTES J, SAINZ R: Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs. Eurj. Gastroenterol Hepatol. (2003) 15:173–178.
- ABRAMSON SB: Et tu, acetaminophen? Arthritis Rheum. (2002) 46:2831–2835.
- ••An evidence-based editorial on GIsafety of paracetamol.
- CRYER BL: Acetaminophen not associated with gastrointestinal toxicity: comment on the article by Rahme et al. Arthritis Rheum. (2003) 48:2074–2075.
- BANNWARTH B: Concerns about gastrointestinal safety of acetaminophen: comment on the article by Rahme et al. Arthritis Rheum. (2003) 46:2075.